Open-sourcing drug development in neuropsychiatry

Elata Biosciences is pioneering an open-source model at the intersection of blockchain and neuropsychiatry. Our mission is to create a decentralized, distributed, and open ecosystem that utilizes blockchain to fund and tokenize novel drug development efforts in high-impact areas across psychiatry.
Join our community

Our mission is to advance psychiatry using open-source principles.

15% +
Of people - or close to 800 million - struggle with a mental health disorder globally.
‍

‍
Several
Psychiatric conditions do not have a specified approved medicine available, while the ones that do generally are insufficient for patients.
‍
$20bn +
Is the estimated value of the global psychiatric IP market, yet has major issues with liquidity and capital allocation.
‍
‍
80% + 
Of technology spinouts originating in academia and government fail, prompting the need for a superior spinout model.

‍

Elata's model aims to serve all contributors

For investors

It is no secret that drug development is a pricey endeavor, and it is no surprise that private markets are generally uninterested in investing in projects with low upside potential. Elata fixes this by providing high upside potential and ROI through issuing an allocation of royalty streams and cashflows stemming from drug sales and licensing agreements amongst tokenholders.

For researchers

Elata is forming a psychiatric innovation unit to advance novel compound research, inviting pioneering researchers to steer early-stage drug development.

Elata aims to unify the psychiatric research community, enhancing collaboration and aligning incentives through a community-focused approach.

For patients

Developing an open community that patients can use is the key and most important part of Elata.

We prioritize patient outcomes by fostering an open community, ensuring that scientific advancements and funding interests align closely with the needs of patients.

Frequently Asked Questions

How does Elata work?

We are an open science effort broadly focused on developing psychiatric medicines, operating within an area known as decentralized science (DeSci). The DeSci movement aims to use blockchain networks to create an open ecosystem around scientific research, ranging from many distinct therapeutic areas and align incentives for all stakeholders - something that has traditionally been very difficult in open source communities. Our goal is to create more effective spinouts than those at traditional institutions by implementing a modular org structure in which the hub is an open, transparent, and decentralized information exchange.

What is the advantage of Elata?

Elata is bringing financial and organizational innovation to the world of drug development and psychiatry - an issue we view as much needed. Our solution aims to operate at the crossroads of various disciplines, and unlike others in the space, we orient ourselves to push a diversified portfolio of medicines forward in an effort to maximize impact for investors, contributors, and patients.

How can I get involved?

We’re growing our community ahead of our token launch. To get involved, you can follow us on X or join our Discord community.